Delayed occurrence of cytomegalovirus disease in organ transplant recipients receiving antiviral prophylaxis: are we winning the battle only to lose the war?
Singh
N
N
D000998:Antiviral Agents / Q000008:administration & dosage*; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control*; D016377:Organ Transplantation / Q000009:adverse effects / Q000379:methods; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D012680:Sensitivity and Specificity; D014181:Transplantation Immunology
D000998:Antiviral Agents